02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
On September 3, 2020, the Department of Justice's Antitrust Division (the DOJ) issued its new Merger...
Read More >
California is set to become the only state to outlaw predispute mandatory arbitration of statutory e...
Read More >
On Friday, December 6 the U.S. Citizenship and Immigration Service (USCIS) announced that it will im...
Read More >
This week the General Assembly of North Carolina provided some relief to developers with active deve...
Read More >
The COVID-19 pandemic has changed most governments' views on the strategic relevance of the domestic...
Read More >
Effective March 16, 2020, COMPS Order #36 (the Order), issued by the Colorado Department of Labor an...
Read More >